• Director Marc Rubin receives 6,800 Curis (CRIS) stock options at $5.29 Stock Titan Thu, 09 Jul 2026 20:13:17 GMT
• Curis (CRIS) director receives grant of 6,800 non-qualified stock options Stock Titan Thu, 09 Jul 2026 20:12:52 GMT
• Curis (CRIS) director John Hohneker receives 6,800 stock options at $5.29 Stock Titan Thu, 09 Jul 2026 20:12:34 GMT
• Curis Inc (CRIS) director receives 6,800 stock options at $5.29 Stock Titan Thu, 09 Jul 2026 20:12:19 GMT
• CURIS INC (CRIS) director granted 6,800 non-qualified stock options at $5.29 Stock Titan Thu, 09 Jul 2026 20:12:01 GMT
• CURIS (CRIS) CFO receives 48,285 stock options at $5.29 exercise price Stock Titan Thu, 09 Jul 2026 20:11:35 GMT
• Curis (CRIS) CDO Jonathan Zung receives 48,285 stock options at $5.29 strike Stock Titan Thu, 09 Jul 2026 20:10:32 GMT
• Curis (CRIS) CEO receives 110,090 employee stock options at $5.29 Stock Titan Thu, 09 Jul 2026 20:10:06 GMT
• cris q1 2026 earnings: wider than expected loss sends shares lower - earnings yield analysis dars.gov.et Tue, 07 Jul 2026 09:48:26 GMT
• curis (cris) advances takeaim cll study with patient enrollment progress GuruFocus Mon, 06 Jul 2026 14:24:29 GMT
• Curis Consents 6 Patients in Phase 2 Trial of Emavusertib in Chronic Lymphocytic Leukemia Moomoo Mon, 06 Jul 2026 14:11:05 GMT
• Curis Lifesciences accepts resignation of independent director scanx.trade Mon, 06 Jul 2026 12:19:37 GMT
• CRIS Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains Absent - Balance Sheet Strength dars.gov.et Sun, 05 Jul 2026 17:30:23 GMT
• curis announces eleven active clinical sites in takeaim cll study, reaffirms patient dosing guidance, and reports stockholder appr... AOL.com Sat, 04 Jul 2026 15:31:24 GMT
• Curis Lifesciences fined Rs 5,900 by NSE for delayed compliance scanx.trade Sat, 04 Jul 2026 05:19:21 GMT
• Curis Inc outlines oncology pipeline as investors watch funding and trial progress AD HOC NEWS Fri, 03 Jul 2026 12:45:44 GMT
• Curis (NASDAQ: CRIS) sets 1-for-20 reverse split and adjusts equity awards Stock Titan Thu, 02 Jul 2026 12:56:56 GMT
• 12 Health Care Stocks Moving In Wednesday's After-Market Session Benzinga Wed, 01 Jul 2026 21:05:46 GMT
• Curis (NASDAQ:CRIS) Will Have To Spend Its Cash Wisely simplywall.st Wed, 01 Jul 2026 18:53:18 GMT
• Curis (CRIS) schedules reverse stock split and split-adjusted trading Stock Titan Wed, 01 Jul 2026 15:23:02 GMT
• Curis (NASDAQ: CRIS) sets 1-for-20 reverse stock split after holder vote Stock Titan Wed, 01 Jul 2026 12:02:46 GMT
• cris q1 2026 earnings: significant earnings miss amid no reported revenue - earnings call q&a dars.gov.et Tue, 30 Jun 2026 23:45:26 GMT
• cris q1 2026 earnings: misses eps estimates significantly; no revenue reported - earnings cycle outlook dars.gov.et Tue, 30 Jun 2026 16:33:38 GMT
• Curis opens 11 sites for emavusertib combo in TakeAim CLL trial Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• $Lucas GC (LGCL.US)$$Curis (CRIS.US)$ coming after you. 😉 shoulda kept some cris. but still got my 2x Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• $Lucas GC (LGCL.US)$ told ya $Curis (CRIS.US)$ yous our my sons Moomoo Sun, 28 Jun 2026 22:24:00 GMT
• Curis (CRIS) Launches Phase 2 CLL Study and Plans Reverse Stock Split GuruFocus Fri, 26 Jun 2026 14:36:54 GMT
• Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Appr... PR Newswire Fri, 26 Jun 2026 07:00:00 GMT
• Curis opens 11 cancer trial sites as reverse split plan advances Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Curis opens 11 sites for CLL study, shareholders approve stock split Investing.com Fri, 26 Jun 2026 07:00:00 GMT
• enterprise value to ebit forward of curis, inc. – nasdaq:cris TradingView Fri, 26 Jun 2026 03:39:09 GMT
• enterprise value to ebitda forward of curis, inc. – ls:a3etjd TradingView Thu, 25 Jun 2026 07:05:01 GMT
• enterprise value to revenue forward of curis, inc. – nasdaq:cris TradingView Thu, 25 Jun 2026 05:36:23 GMT
• Curis (CRIS) Stock Faces Mixed Analyst Target Changes Over Execution And Pipeline Risk Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• curis inc. (cris) edges higher: testing key resistance amid speculative trading - breakout stock alerts dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• curis inc (cris) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 09:04:57 GMT
• curis inc (cris) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 00:34:30 GMT
• curis inc (cris) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 22:59:06 GMT
• curis inc (cris) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• curis inc (cris) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• curis inc (cris) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• curis inc (cris) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 09:24:58 GMT
• curis inc (cris) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 08:51:25 GMT
• curis inc (cris) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 06:49:14 GMT
• curis inc stock (us2312691006): quarterly earnings keep biotech micro-cap in focus Ad-hoc-news.de Tue, 16 Jun 2026 18:07:29 GMT
• cris q1 2026 earnings: deep eps miss highlights pre-revenue challenges amid strategic pivot - earnings weakness phase dars.gov.et Wed, 10 Jun 2026 07:00:00 GMT
• curis stock (us2312691006): cancer biotech faces nasdaq compliance deadline after reverse stock spli AD HOC NEWS Tue, 09 Jun 2026 18:35:32 GMT
• Curis (NASDAQ: CRIS) plans reverse stock split to address Nasdaq bid price Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• curis lifesciences promoters report no share encumbrance in fy26 scanx.trade Wed, 03 Jun 2026 03:18:00 GMT
• Curis Lifesciences promoters report no share encumbrance in FY26 scanx.trade Tue, 02 Jun 2026 07:00:00 GMT
• cris financials: revenue breakdown, margins & competitor comparison Intellectia AI Mon, 01 Jun 2026 13:21:43 GMT
• curis lifesciences fy26 net profit rises 11.4% to ₹691.63 lakh scanx.trade Mon, 01 Jun 2026 07:00:00 GMT
• curis lifesciences fy26 net profit rises 11.4% to ₹691.63 lakh scanx.trade Sun, 31 May 2026 04:29:17 GMT
• Curis | PRE 14A: Preliminary proxy statements relating to merger or acquisition Moomoo Fri, 22 May 2026 07:00:00 GMT
• curis (nasdaq: cris) wins shareholder approval to double authorized common stock Stock Titan Fri, 22 May 2026 07:00:00 GMT
• curis stock (us2312691006): phase 1 data update lifts attention AD HOC NEWS Thu, 21 May 2026 08:45:52 GMT
• curis to host webcast to discuss updated emavusertib clinical da GuruFocus Tue, 19 May 2026 03:38:49 GMT
• curis faces nasdaq delisting determination, plans appeal hearing TipRanks Mon, 18 May 2026 22:17:36 GMT
• curis stock (us2312691006): cancer drug setback keeps investors on edge AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• curis stock (us2312691006): cancer pipeline update keeps investors cautious AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• armistice capital (nasdaq: cris) reports 4.99% ownership of curis Stock Titan Fri, 15 May 2026 07:00:00 GMT
• jonestrading maintains curis(cris.us) with buy rating, maintains target price $5 Moomoo Thu, 14 May 2026 18:55:39 GMT
• curis, inc. (nasdaq:cris) q1 2026 earnings call transcript Insider Monkey Thu, 14 May 2026 12:24:51 GMT
• thomas satterfield holds 3.96m shares as curis (cris) ownership amended Stock Titan Thu, 14 May 2026 07:00:00 GMT
• curis, inc. (cris) reports q1 2026 loss and updates on clinical trials GuruFocus Wed, 13 May 2026 15:27:15 GMT
• curis reaffirmed at buy as analyst maintains $5 price target on emavusertib clinical catalysts in cll and pcnsl TipRanks Wed, 13 May 2026 14:13:52 GMT
• curis buy rating reiterated as analyst highlights dual-blockade progress and clinical catalysts; $17 price target maintained TipRanks Wed, 13 May 2026 13:01:21 GMT
• curis anticipates takeaim cll initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27 MSN Wed, 13 May 2026 10:31:05 GMT
• curis inc 1q 2026: revenue $0 net income ($24.2m), eps ($1.25) — 10-q summary TradingView Wed, 13 May 2026 07:00:00 GMT
• curis q1 2026 deep dive: eps misses by 331.0%, revenue down 100% AlphaStreet Wed, 13 May 2026 07:00:00 GMT
• curis (nasdaq: cris) posts larger q1 2026 loss and warns on going concern Stock Titan Wed, 13 May 2026 07:00:00 GMT
• curis inc (cris) q1 2026 earnings call highlights: progress in l GuruFocus Wed, 13 May 2026 06:32:55 GMT
• curis (cris) expects sufficient funding to support operations un GuruFocus Wed, 13 May 2026 02:23:48 GMT
• earnings call transcript: curis q1 2026 reveals widened net loss Investing.com UK Wed, 13 May 2026 01:19:35 GMT
• curis (cris) q1 miss: eps -$1.25 vs -$0.40 est, revenue $0 vs $1 GuruFocus Wed, 13 May 2026 00:25:28 GMT
• curis sees cash and proceeds enough for operations into second half of fy27 TipRanks Tue, 12 May 2026 22:11:49 GMT
• Curis (CRIS) Q1 Miss: EPS -$1.25 vs -$0.40 est, Revenue $0 vs $1 GuruFocus Tue, 12 May 2026 07:00:00 GMT
• curis (nasdaq: cris) posts larger q1 2026 loss and flags funding needs Stock Titan Tue, 12 May 2026 07:00:00 GMT
• curis reports q1 loss, expects cll trial milestone by mid-2026 Investing.com Tue, 12 May 2026 07:00:00 GMT
• earnings call transcript: curis q1 2026 reveals widened net loss by investing.com Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• curis inc reports results for the quarter ended march 31 - earnings summary TradingView Tue, 12 May 2026 07:00:00 GMT
• curis, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• curis reports q1 2026 results: full earnings call transcript Benzinga Tue, 12 May 2026 07:00:00 GMT
• curis (cris) expects sufficient funding to support operations un GuruFocus Tue, 12 May 2026 07:00:00 GMT
• curis to report first quarter 2026 financial and operating results and host conference call and webcast on may 12, 2026 Barchart.com Mon, 11 May 2026 22:36:46 GMT
• curis inc expected to post a loss of 40 cents a share - earnings preview TradingView Fri, 08 May 2026 20:30:10 GMT
• curis announces pricing of private placement totaling up to $80.8 million in gross proceeds Quantisnow Fri, 08 May 2026 10:08:58 GMT
• curis to report second quarter 2024 financial and operating results and host conference call and webcast on august 1, 2024 Quantisnow Fri, 08 May 2026 04:35:12 GMT
• earnings preview: curis to report financial results post-market on may 12 Moomoo Thu, 07 May 2026 01:00:27 GMT
• Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 BioSpace Wed, 06 May 2026 07:00:00 GMT
Curis, Inc(NASDAQ:CRIS) 
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment o...
Website: http://www.curis.com
Founded: 2000
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology